Wright B, Kang D, Schuette A, Ward M, Krasowski M, Scherer A
Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e190.
PMID: 39465214
PMC: 11505257.
DOI: 10.1017/ash.2024.420.
Chun H, Lodiongo D, Milligan K, Lesuk G, Patel D, Shiraishi R
IJID Reg. 2024; 12:100421.
PMID: 39281194
PMC: 11399597.
DOI: 10.1016/j.ijregi.2024.100421.
Helou M, Zoghbi S, El Osta N, Mina J, Mokhbat J, Husni R
Medicine (Baltimore). 2023; 102(17):e32992.
PMID: 37115042
PMC: 10143398.
DOI: 10.1097/MD.0000000000032992.
Dudeja M, Shaikh A, Islam F, Alvi Y, Ahmad M, Kashyap V
PLoS One. 2023; 18(1):e0265290.
PMID: 36662835
PMC: 9858779.
DOI: 10.1371/journal.pone.0265290.
Vaezi A, Fakhim H, Abbasi S, Masoudi S, Rizi M, Javanmard S
Antibodies (Basel). 2023; 12(1).
PMID: 36648886
PMC: 9844358.
DOI: 10.3390/antib12010002.
Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F, Mukahal M, AlQurashi A, Huq M, Alabdrabalnabi F, AlJurayyan A
PLoS One. 2022; 17(8):e0272818.
PMID: 35960736
PMC: 9374211.
DOI: 10.1371/journal.pone.0272818.
COVID-19 seroprevalence after the first UK wave of the pandemic and its association with the physical and mental wellbeing of secondary care healthcare workers.
Sethi S, Manuelpillai N, Mandal A, Simpson O, Morrissey H, Ball P
Brain Behav Immun Health. 2022; 24:100492.
PMID: 35957800
PMC: 9355737.
DOI: 10.1016/j.bbih.2022.100492.
[Anti-SARS-CoV-2 seroprevalence in administrative staff of the Mexican Institute for Social Security].
Cedeno-Cuellar M, Luna-Vargas A, Garcia-Hernandez E, Vargas-Madrid S, Sanchez-Canas J, Galvan-Bobadilla A
Rev Med Inst Mex Seguro Soc. 2022; 60(3):297-303.
PMID: 35763356
PMC: 10396060.
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.
Azami M, Moradi Y, Moradkhani A, Aghaei A
Eur J Med Res. 2022; 27(1):81.
PMID: 35655237
PMC: 9160514.
DOI: 10.1186/s40001-022-00710-2.
Seroprevalence and Dynamics of anti-SARS-CoV-2 antibody among healthcare workers following ChAdOx1 nCoV-19 vaccination.
Sarkar S, Das S, Choudhury K, Mukherjee S, Chatterjee R
Epidemiol Infect. 2022; :1-20.
PMID: 35465866
PMC: 9068497.
DOI: 10.1017/S0950268822000747.
Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19.
Haq M, Rehman A, Haq M, Haq H, Rajab H, Ahmad J
Ther Adv Vaccines Immunother. 2022; 10:25151355221080724.
PMID: 35295994
PMC: 8918754.
DOI: 10.1177/25151355221080724.
Seropositivity of Anti-SARS CoV2 IgG antibodies in health care workers of an Indian tertiary care hospital during COVID-19.
Verma A, Shukla S, Verma A, Puri B, Jain A
Indian J Med Microbiol. 2022; 40(2):228-230.
PMID: 35277299
PMC: 8903802.
DOI: 10.1016/j.ijmmb.2022.02.004.
SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak.
Korona-Glowniak I, Mielnik M, Podgajna M, Grywalska E, Hus M, Matuska K
Int J Environ Res Public Health. 2022; 19(4).
PMID: 35206504
PMC: 8871845.
DOI: 10.3390/ijerph19042319.
German and international studies on SARS-CoV-2 seroprevalence.
Poethko-Muller C, Prutz F, Buttmann-Schweiger N, Fiebig J, Sarganas G, Seeling S
J Health Monit. 2022; 5(Suppl 4):2-15.
PMID: 35146294
PMC: 8734155.
DOI: 10.25646/7024.
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
Halili R, Bunjaku J, Gashi B, Hoxha T, Kamberi A, Hoti N
BMC Infect Dis. 2022; 22(1):57.
PMID: 35034617
PMC: 8761334.
DOI: 10.1186/s12879-022-07038-6.
Prevalence of SARS-CoV-2 Infection in a Sample of Health Workers in Two Health Departments of the Valencian Community in Spain.
Rodriguez de Limia Ramirez K, Ruiz-Robledillo N, Duro-Torrijos J, Garcia-Roman V, Albaladejo-Blazquez N, Ferrer-Cascales R
Int J Environ Res Public Health. 2022; 19(1).
PMID: 35010325
PMC: 8751085.
DOI: 10.3390/ijerph19010066.
Evaluation of SARS-CoV-2 antibody responses in healthcare workers at a tertiary care COVID 19 dedicated hospital in Delhi.
Sherwal B, Bhattar S, Sabharwal S, Jain A, Saxena S, Bargotya M
Indian J Med Microbiol. 2021; 40(1):30-34.
PMID: 34801631
PMC: 8598941.
DOI: 10.1016/j.ijmmb.2021.11.006.
Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
Bryan A, Tatem K, Diuguid-Gerber J, Cooke C, Romanoff A, Choudhury N
BMJ Open. 2021; 11(11):e053158.
PMID: 34732494
PMC: 8572359.
DOI: 10.1136/bmjopen-2021-053158.
SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls.
Heyming T, Bacon K, Lara B, Knudsen-Robbins C, Tongol A, Sanger T
Infect Dis Rep. 2021; 13(4):910-916.
PMID: 34698190
PMC: 8544562.
DOI: 10.3390/idr13040082.
Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman.
Al-Naamani K, Al-Jahdhami I, Al-Tamtami W, Al-Amri K, Al-Khabori M, Al Sinani S
J Infect Public Health. 2021; 14(11):1578-1584.
PMID: 34688980
PMC: 8442291.
DOI: 10.1016/j.jiph.2021.09.006.
